166 related articles for article (PubMed ID: 35432823)
1. Establishment and Analysis of Hypoxia-Related Model in Oral Squamous Cell Carcinoma.
Lu X; Liu X
J Healthc Eng; 2022; 2022():6602648. PubMed ID: 35432823
[TBL] [Abstract][Full Text] [Related]
2. A Novel Immune-Related Gene Signature to Identify the Tumor Microenvironment and Prognose Disease Among Patients With Oral Squamous Cell Carcinoma Patients Using ssGSEA: A Bioinformatics and Biological Validation Study.
Chen Y; Feng Y; Yan F; Zhao Y; Zhao H; Guo Y
Front Immunol; 2022; 13():922195. PubMed ID: 35935989
[TBL] [Abstract][Full Text] [Related]
3. A four-hypoxia-genes-based prognostic signature for oral squamous cell carcinoma.
Zhao C; Zhou Y; Ma H; Wang J; Guo H; Liu H
BMC Oral Health; 2021 May; 21(1):232. PubMed ID: 33941139
[TBL] [Abstract][Full Text] [Related]
4. Gene Expression Clustering and Selected Head and Neck Cancer Gene Signatures Highlight Risk Probability Differences in Oral Premalignant Lesions.
Carenzo A; Serafini MS; Roca E; Paderno A; Mattavelli D; Romani C; Saintigny P; Koljenović S; Licitra L; De Cecco L; Bossi P
Cells; 2020 Aug; 9(8):. PubMed ID: 32756466
[TBL] [Abstract][Full Text] [Related]
5. Identification of Candidate Target Genes and Immune Cells in Oral Squamous Cell Carcinoma.
Xie P; Wu S; Guo L; Ren J; Cai K; Zhou M; Liu W; Yang S
Comput Math Methods Med; 2021; 2021():5802110. PubMed ID: 35003322
[TBL] [Abstract][Full Text] [Related]
6. Ferroptosis-associated DNA methylation signature predicts overall survival in patients with head and neck squamous cell carcinoma.
Xu Y; Hong M; Kong D; Deng J; Zhong Z; Liang J
BMC Genomics; 2022 Jan; 23(1):63. PubMed ID: 35042463
[TBL] [Abstract][Full Text] [Related]
7. A Prognostic Model Based on Cisplatin-Resistance Related Genes in Oral Squamous Cell Carcinoma.
Lu R; Yang Q; Liu S; Sun L
Oral Health Prev Dent; 2024 Jan; 22(1):39-50. PubMed ID: 38223960
[TBL] [Abstract][Full Text] [Related]
8. Development of a lncRNA-based prognostic signature for oral squamous cell carcinoma.
Xu Z; Li X; Pan L; Tan R; Ji P; Tang H
J Oral Pathol Med; 2022 Apr; 51(4):358-368. PubMed ID: 35100473
[TBL] [Abstract][Full Text] [Related]
9. A Five-mRNA Expression Signature to Predict Survival in Oral Squamous Cell Carcinoma by Integrated Bioinformatic Analyses.
Guo H; Li C; Su X; Huang X
Genet Test Mol Biomarkers; 2021 Aug; 25(8):517-527. PubMed ID: 34406843
[No Abstract] [Full Text] [Related]
10. Development and validation of a hypoxia-immune-based microenvironment gene signature for risk stratification in gastric cancer.
Liu Y; Wu J; Huang W; Weng S; Wang B; Chen Y; Wang H
J Transl Med; 2020 May; 18(1):201. PubMed ID: 32410620
[TBL] [Abstract][Full Text] [Related]
11. Development of a prediction model for radiotherapy response among patients with head and neck squamous cell carcinoma based on the tumor immune microenvironment and hypoxia signature.
Zhu GL; Yang KB; Xu C; Feng RJ; Li WF; Ma J
Cancer Med; 2022 Dec; 11(23):4673-4687. PubMed ID: 35505641
[TBL] [Abstract][Full Text] [Related]
12. Construction of a hypoxia-derived gene model to predict the prognosis and therapeutic response of head and neck squamous cell carcinoma.
Wang H; Zheng L
Sci Rep; 2022 Aug; 12(1):13538. PubMed ID: 35945448
[TBL] [Abstract][Full Text] [Related]
13. Identification of Prognostic and Tumor Microenvironment by Shelterin Complex-Related Signatures in Oral Squamous Cell Carcinoma.
Zhang S; Yu H; Li J; Zhao L; Tan L; Song Q; Sun C
Oxid Med Cell Longev; 2022; 2022():6849304. PubMed ID: 35757510
[TBL] [Abstract][Full Text] [Related]
14. Up-regulation of extracellular-matrix and inflammation related genes in oral squamous cell carcinoma.
Thakore VP; Patel KD; Vora HH; Patel PS; Jain NK
Arch Oral Biol; 2024 May; 161():105925. PubMed ID: 38442470
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of a hypoxia-related gene pair signature to predict overall survival in head and neck squamous cell carcinoma.
Ding Z; Li H; Yu D
Eur Arch Otorhinolaryngol; 2021 Oct; 278(10):3973-3983. PubMed ID: 33449166
[TBL] [Abstract][Full Text] [Related]
16. Characterization of Cancer Stem Cell Characteristics and Development of a Prognostic Stemness Index Cell-Related Signature in Oral Squamous Cell Carcinoma.
Feng J; Li Y; Wen N
Dis Markers; 2021; 2021():1571421. PubMed ID: 34840626
[TBL] [Abstract][Full Text] [Related]
17. A pyroptosis-related lncRNA signature predicts prognosis and immune microenvironment in head and neck squamous cell carcinoma.
Zhu W; Ye Z; Chen L; Liang H; Cai Q
Int Immunopharmacol; 2021 Dec; 101(Pt B):108268. PubMed ID: 34688154
[TBL] [Abstract][Full Text] [Related]
18. Identification of prognostic genes in oral squamous cell carcinoma microenvironment.
Zhu L; Zhang X; Chen Y; Yan D; Han J
Cancer Biomark; 2022; 34(4):523-532. PubMed ID: 35275524
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of a fourteen- innate immunity-related gene pairs signature for predicting prognosis head and neck squamous cell carcinoma.
Zhang F; Liu Y; Yang Y; Yang K
BMC Cancer; 2020 Oct; 20(1):1015. PubMed ID: 33081731
[TBL] [Abstract][Full Text] [Related]
20. Identification of an Immune Score-Based Gene Panel with Prognostic Power for Oral Squamous Cell Carcinoma.
Huang SN; Li GS; Zhou XG; Chen XY; Yao YX; Zhang XG; Liang Y; Li MX; Chen G; Huang ZG; Dang YW; Li J; Li P; Tang XZ; Rong MH
Med Sci Monit; 2020 Jun; 26():e922854. PubMed ID: 32529991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
